Clinical trial
Effect of Septal Closure of Atrial PFO on Events of Migraine With Premere: ESCAPE Migraine Trial
NCT00267371 is registered in ClinicalTrials.gov with Abbott Medical Devices as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effect of Septal Closure of Atrial PFO on Events of Migraine With Premere: ESCAPE Migraine Trial
- Lead sponsor
- Abbott Medical Devices
- Phase
- Phase 3
- Overall status
- Terminated
- Start date
- November 30, 2005
- Completion date
- March 31, 2012
- Enrollment
- 168 (actual)
- Sites
- 37
Conditions
As the registry lists them; a condition with its own page is linked.